Ardelyx reported $-26040000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.5B 703M
Amgen AMGN:US USD 3.5B 62M
Astrazeneca AZN:US USD 3.6B 404M
Chimerix CMRX:US USD 11.67M 35.09M
Corcept Therapeutics CORT:US USD 32.13M 581K
Life Technologies LIFE:US USD -13443000 922K
Tg Therapeutics TGTX:US USD -34887000 3.98M
United Therapeutics UTHR:US USD 327.2M 112.7M
Xoma XOMA:US USD -4368000 398K